Superworth

Bio-Rad Laboratories price to book ratio BIO

Market value divided by the book value of the company's net assets, since 2011.

Today, Oct 23, 2026
1.4×
10-year median
1.6×
Against its 10-year history
37th
percentile: 0 is its lowest day, 100 its highest
10-year range
0.9× to 2.9×
Peer median
5.0×

Bio-Rad Laboratories' price to book ratio is 1.4× as of Oct 23, 2026.

That is below its ten-year median of 1.6×, close to the middle of its last ten years.

Over that time it ranged from 0.9× in Jun 2024 to 2.9× in Mar 2018.

The median for 10 diagnostics and research stocks of a similar size is 5.0×.

Price to book ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far1.4×0.9×1.4×
20251.2×0.9×1.3×
20241.2×0.9×1.4×
20231.1×0.9×1.7×
20221.5×1.1×1.8×
20211.5×1.4×2.2×
20202.0×1.7×2.5×
20192.1×1.4×2.3×
20181.4×1.4×2.9×
20172.5×2.0×2.8×
20162.0×1.5×2.0×
20151.7×1.5×2.0×
20141.6×1.4×1.8×
20131.7×1.6×1.8×
20121.5×1.5×1.8×
20111.6×1.5×1.7×

Against its peers

Companies in Medical - Diagnostics & Research nearest Bio-Rad Laboratories' size, closest first, today.

CompanyPrice to book ratio
BIOBio-Rad Laboratories1.4×
CAICaris Life Sciences15.3×
LNTHLantheus5.0×
RVTYRevvity2.5×
MEDPMedpace43.1×
BLLNBillionToOne9.5×
VCYTVeracyte2.8×
LHLabcorp3.1×
DGXQuest Diagnostics3.6×
CDNACareDx8.4×
MTDMettler-Toledo Internationaln/m
Peer median5.0×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on Bio-Rad Laboratories

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.